Badawy Abdelbasset A, Saleem Mohamed D, Abolyosr Ahmad, Abuzeid Abdelmoneim M
Urology Department, Sohag Faculty of Medicine, Sohag, Egypt.
Urology Department, Qena University Hospital, South Valley University, Qena, Egypt.
Arab J Urol. 2012 Jun;10(2):182-5. doi: 10.1016/j.aju.2012.02.010. Epub 2012 Apr 21.
To evaluate the safety and clinical efficacy of the transobturator vaginal tape 'inside-out' (TVT-O) procedure for managing new-onset stress urinary incontinence (SUI) after radical cystectomy (RC) and orthotopic W-neobladder construction in women.
Between January 2004 and June 2010, 57 women were treated with RC and orthotopic ileal neobladder reconstruction. Six of these patients (median age 44 years, range 39-62; grade 2 muscle-invasive squamous cell carcinoma in four and transitional cell carcinoma in two) developed de novo SUI that was moderate in four and severe in two. The median (range) duration of SUI was 11 (9-18) months. All six patients underwent TVT-O for control of their SUI.
Four patients were completely dry day and night (three of them can initiate voiding and one cannot, and uses intermittent catheterization). One patient improved, as assessed by using fewer pads (from 5-7 pads to 1 pad/day and night). She can initiate voiding but has minimal leakage only on moderate exertion. One patient who had severe SUI showed no improvement. Patients were followed for a mean (range) of 18 (17-32) months, with no deterioration in the continence status.
These encouraging results confirm the safety and clinical efficacy of TVT-O for managing new-onset SUI after RC and ileal neobladder construction, although a larger survey and a longer follow-up are needed.
评估经闭孔阴道吊带“由内向外”(TVT - O)手术治疗女性根治性膀胱切除术(RC)和原位W形新膀胱构建术后新发压力性尿失禁(SUI)的安全性和临床疗效。
2004年1月至2010年6月期间,57例女性接受了RC和原位回肠新膀胱重建术。其中6例患者(中位年龄44岁,范围39 - 62岁;4例为2级肌层浸润性鳞状细胞癌,2例为移行细胞癌)出现新发SUI,4例为中度,2例为重度。SUI的中位(范围)持续时间为11(9 - 18)个月。所有6例患者均接受TVT - O手术以控制其SUI。
4例患者日夜完全干爽(其中3例可自主排尿,1例不能自主排尿,采用间歇性导尿)。1例患者情况改善,根据使用护垫数量评估(从每天5 - 7片减少到每天日夜各1片)。她可以自主排尿,但仅在剧烈运动时有少量漏尿。1例重度SUI患者无改善。患者平均(范围)随访18(17 - 32)个月,尿失禁状态无恶化。
这些令人鼓舞的结果证实了TVT - O手术治疗RC和回肠新膀胱构建术后新发SUI的安全性和临床疗效,尽管需要更大规模的调查和更长时间的随访。